Tin tức & Cập nhật

New drug applications approved by US FDA as of 16-31 July 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

The risk of atherosclerotic cardiovascular disease (ASCVD) events increases by more than fourfold in the presence of polyendocrine metabolic ovarian syndrome (PMOS), according to a retrospective study from the US.

A recent study suggests the clinical value of coronary artery calcium (CAC) when statin treatment decisions are uncertain, especially among individuals with borderline predicted risk.

Individuals with greater adherence to The Dietary Approaches to Stop Hypertension (DASH) diet have reduced risks of heart failure (HF) and HF-related death, as suggested in a study.

Physical activity helps lower the risks of stroke and mortality, regardless of the presence of atrial fibrillation (AF), according to the Norwegian population-based Tromsø and HUNT studies.

For patients with permanent pacemakers, newly diagnosed mental disorders are associated with elevated risk of long-term mortality, according to a study. The association is especially pronounced among younger men and those with early-onset mental disorders.

Adding the investigational selective prostacyclin receptor agonist ralinepag to background therapy helps reduce the risk of first clinical worsening in patients with pulmonary arterial hypertension (PAH), according to the phase III ADVANCE-OUTCOMES trial.

Individuals with greater skeletal muscle mass (SMM) may have higher blood pressure (BP) and left ventricular mass index (LVMI), regardless of adiposity, reveals a study.